Evaluation of ROTARIX

Simple item page
dc.contributor.affiliationDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
dc.contributor.affiliationDepartment of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Centers, University of Amsterdam, Paasheuvelweg 25, 1105 BP Amsterdam, The Netherlands.
dc.contributor.affiliationDivision of Medical Microbiology, Department of Pathology, Stellenbosch University & National Health Laboratory Service, Tygerberg Hospital Francie van Zijl Drive, Tygerberg, P.O. Box 241, Cape Town 8000, South Africa.
dc.contributor.affiliationDepartment of Biostatistics, School of Public Health, University of Ghana, Accra P.O. Box LG13, Ghana.
dc.contributor.affiliationFlow Cytometry and Immunology Facility, Medical Research Council Unit, The Gambia at London School of Hygiene and Tropical Medicine, Fajara, Banjul P.O. Box 273, The Gambia.
dc.contributor.affiliationDepartment of Biomedical Sciences, School of Health Sciences, University of Zambia, Lusaka P.O. Box 50110, Zambia.
dc.contributor.affiliationEnteric Disease and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka P.O. Box 34681, Zambia.
dc.contributor.affiliationCIDRZ
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.contributor.authorLaban NM
dc.contributor.authorBosomprah S
dc.contributor.authorSimuyandi M
dc.contributor.authorChibuye M
dc.contributor.authorChauwa A
dc.contributor.authorChirwa-Chobe M
dc.contributor.authorSukwa N
dc.contributor.authorChipeta C
dc.contributor.authorVelu R
dc.contributor.authorNjekwa K
dc.contributor.authorMubanga C
dc.contributor.authorMwape I
dc.contributor.authorGoodier MR
dc.contributor.authorChilengi R
dc.date.accessioned2025-05-23T11:40:39Z
dc.date.issued2023-Feb-03
dc.description.abstractOral rotavirus vaccines show diminished immunogenicity in low-resource settings where rotavirus burden is highest. This study assessed the safety and immune boosting effect of a third dose of oral ROTARIX
dc.identifier.doi10.3390/vaccines11020346
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/10261
dc.sourceVaccines
dc.titleEvaluation of ROTARIX

Files

Collections

Published